<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02956304</url>
  </required_header>
  <id_info>
    <org_study_id>D15-P13</org_study_id>
    <nct_id>NCT02956304</nct_id>
  </id_info>
  <brief_title>&quot; Effect of Affordance of Objects on the Memory: Study in Transcranial Magnetic Stimulation &quot;</brief_title>
  <acronym>SIMULANG-TMS</acronym>
  <official_title>&quot; Effect of Affordance of Objects on the Memory: Study in Transcranial Magnetic Stimulation &quot; (SIMULANG-TMS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier St Anne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Paris 5 - Rene Descartes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier St Anne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is determine the involvement of motor system in the memory of
      manipulable objects. The idea is to stimulate the ventral premotor cortex with transcranial
      magnetic stimulation to see whether this stimulation will affect memory of manipulable
      objects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Embodied cognition claims that representations shares processing resources with sensorimotor
      systems. More specifically, it has been proposed that language comprehension relies on
      internal simulation of the meaning. For instance, numerous studies have shown that the
      processing of action-related concepts involve a motor activation similar to when the action
      is actually performed. However, even if those studies show clearly that action-related
      concepts involve a motor activation, such activations may be incidental to the activation of
      their representations, rather than part of it. Another way to show that this motor component
      takes part in the representation of manipulable objetcs is to investigate whether an
      impairment of motor system would impair the memory of manipulable object. In this study,
      investigators will use Transcranial Magnetic Stimulation (TMS) to stimulate ventral premotor
      cortex (PMv) to see whether this stimulation will affect memory of manipulable objects, but
      not memory of nonmanipulable objects. For this purpose, three TMS conditions will be
      assessed: cTBS to inhibit the motor cortex, iTBS to excite the motor cortex, and a SHAM
      condition as control.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of objects affordants and of objects not - affordants reminded</measure>
    <time_frame>1 week</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is in PMv or control</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of objects affordants and of objects not - affordants reminded</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is in PMv or control</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of objects affordants and of objects not - affordants reminded</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is in PMv or control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of object reminded</measure>
    <time_frame>1 week</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is excitation or control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of object reminded</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is excitation or control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of object reminded</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measure of the number of objects affordants and of objects not - affordants reminded according to if the stimulation is excitation or control</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Group iTBS-cTBS-SHAM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PMv stimulation (iTBS) at session 2, PMv inhibition (cTBS) at session 3, and control (SHAM) at session 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group iTBS-SHAM-cTBS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PMv stimulation (iTBS) at session 2, control (SHAM) at session 3, and PMv inhibition (cTBS) at session 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group cTBS-iTBS-SHAM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PMv inhibition (cTBS) at session 2, PMv stimulation (iTBS) at session 3, and control (SHAM) at session 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group cTBS-SHAM-iTBS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PMv inhibition (cTBS) at session 2, control (SHAM) at session 3, and PMv stimulation (iTBS) at session 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group SHAM-iTBS-cTBS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>control (SHAM) at session 2, PMv stimulation (iTBS) at session 3, and PMv inhibition (cTBS) at session 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group SHAM-cTBS-iTBS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>control (SHAM) at session 2, PMv inhibition (cTBS) at session 3, and PMv stimulation (iTBS) at session 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PMv stimulation (iTBS)</intervention_name>
    <description>PMv stimulation (iTBS)</description>
    <arm_group_label>Group iTBS-cTBS-SHAM</arm_group_label>
    <arm_group_label>Group iTBS-SHAM-cTBS</arm_group_label>
    <arm_group_label>Group cTBS-iTBS-SHAM</arm_group_label>
    <arm_group_label>Group cTBS-SHAM-iTBS</arm_group_label>
    <arm_group_label>Group SHAM-iTBS-cTBS</arm_group_label>
    <arm_group_label>Group SHAM-cTBS-iTBS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PMv inhibition (cTBS)</intervention_name>
    <description>PMv inhibition (cTBS)</description>
    <arm_group_label>Group iTBS-cTBS-SHAM</arm_group_label>
    <arm_group_label>Group iTBS-SHAM-cTBS</arm_group_label>
    <arm_group_label>Group cTBS-iTBS-SHAM</arm_group_label>
    <arm_group_label>Group cTBS-SHAM-iTBS</arm_group_label>
    <arm_group_label>Group SHAM-iTBS-cTBS</arm_group_label>
    <arm_group_label>Group SHAM-cTBS-iTBS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control (SHAM)</intervention_name>
    <description>Control (SHAM)</description>
    <arm_group_label>Group iTBS-cTBS-SHAM</arm_group_label>
    <arm_group_label>Group iTBS-SHAM-cTBS</arm_group_label>
    <arm_group_label>Group cTBS-iTBS-SHAM</arm_group_label>
    <arm_group_label>Group cTBS-SHAM-iTBS</arm_group_label>
    <arm_group_label>Group SHAM-iTBS-cTBS</arm_group_label>
    <arm_group_label>Group SHAM-cTBS-iTBS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 and 35 years

          -  Right-handers (score between 70 and 100 on the scale of Edinburgh)

          -  Native language : French

          -  Not depressed (score lower than 14 in the BDI)

          -  health insurance

          -  Consent

        Exclusion Criteria:

          -  Psychiatric family history up to the second degree

          -  Medical treatment, in particular psychotropic being able to affect the memory and the
             attention

          -  view or hearing disorders (not compensated)

          -  neurological histories (epilepsy, alcoholism in particular) or psychiatric or
             important memory complaints

          -  Contraindications for the SMT

          -  contraindications in the MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascale PIOLINO</last_name>
    <role>Study Director</role>
    <affiliation>University of Paris 5 - Rene Descartes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benoit CREPON, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHSA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benoit CREPON, MD</last_name>
    <phone>00 33 1 45 65 87 70</phone>
    <email>b.crepon@ch-sainte-anne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie GODARD</last_name>
    <phone>00 33 1 45 65 77 28</phone>
    <email>marie.godard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche Clinique (CRC) - CHSA</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Macarena CUENCA</last_name>
      <email>m.cuenca@ch-sainte-anne.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cecile Bergot</last_name>
      <phone>00 33 1 45 65 84 90</phone>
      <email>c.bergot@ch-sainte-anne.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Macarena CUENCA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2016</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

